Evidence map›Paper›PMID 41079397›Full record

ArticleAdvances in statistical analysis : AStA : a journal of the German Statistical Society2025

Machine Learning Approach for Analyzing Mixed Case Interval Censored Data with a Cured Subgroup.

Wisdom Aselisewine, Suvra Pal

Abstract read
In one paragraph

Article in Advances in statistical analysis : AStA : a journal of the German Statistical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wisdom AselisewineDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.
Suvra PalDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.

Funding

Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional SettingsR35GM156859 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI SUVRA PAL · 2025 to 2026
$643k
Using Machine Learning to Improve the Predictive Accuracy of Disease CureR15GM150091 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI PAL, SUVRA · 2023 to 2023
$452k
NIGMS NIH HHS R15 GM150091NIGMS NIH HHS R35 GM156859
6 · The paper itself

Abstract

We introduce a novel two-component framework for analyzing mixed case interval censored (MCIC) data featuring a cured subgroup. In such data, the time-to-event is known only within certain intervals determined by multiple random examination time points. Moreover, a portion of the subjects will never experience the event. The first component of our model focuses on estimating the likelihood of being cured (incidence), departing from the conventional generalized linear model to adopt a more adaptable support vector machine (SVM) approach capable of accommodating complex or non-linear covariate effects. The second component addresses the survival distribution of the uncured individuals (latency) and employs a Cox proportional hazards structure to maintain the straightforward interpretation of covariate effects. We develop an expectation maximization algorithm, incorporating the Platt scaling method, to estimate the probability of being cured. Our simulation study demonstrates that our model outperforms both logit-based and spline-based models in capturing complex classification boundaries, leading to more accurate estimates of cured/uncured probabilities and enhanced predictive accuracy for cure. We emphasize that enhancing the estimation accuracy regarding incidence subsequently improves the estimation outcomes concerning latency. Finally, we illustrate the efficacy of our methodology by applying it to the NASA's Hypobaric Decompression Sickness Data.

Indexed as

EM algorithmMixture cure modelSupport vector machine

Identifiers

PMID41079397
PMCPMC12514071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.